The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease

[1]  K. Belov,et al.  Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer , 2018, Mammalian Genome.

[2]  F. Bemelman,et al.  Transmission of breast cancer by a single multiorgan donor to 4 transplant recipients , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  Stacey Price,et al.  The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils , 2018, Cancer cell.

[4]  S. Beck,et al.  Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor , 2018, Cancer cell.

[5]  Jisung Park,et al.  Pharmacologic inhibition of STAT5 in acute myeloid leukemia , 2018, Leukemia.

[6]  R. Mirsky,et al.  Changes in the Coding and Non-coding Transcriptome and DNA Methylome that Define the Schwann Cell Repair Phenotype after Nerve Injury , 2017, Cell reports.

[7]  Jisung Park,et al.  High‐throughput thermofluor‐based assays for inhibitor screening of STAT SH2 domains , 2017, Journal of pharmaceutical and biomedical analysis.

[8]  J. Deakin,et al.  Identification of candidate genes for devil facial tumour disease tumourigenesis , 2017, Scientific Reports.

[9]  S. Pyecroft,et al.  ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1) , 2017, PloS one.

[10]  Yuka Kanno,et al.  Mechanisms and consequences of Jak–STAT signaling in the immune system , 2017, Nature Immunology.

[11]  A. B. Lyons,et al.  Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils , 2017, Scientific Reports.

[12]  Xiaonan Han,et al.  Steering of carcinoma progression by the YIN/YANG interaction of STAT1/STAT3. , 2017, Bioscience trends.

[13]  P. Lai,et al.  CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence , 2016, Oncogene.

[14]  S. Goff,et al.  A Sixth Modality of Infectious Disease: Contagious Cancer from Devils to Clams and Beyond , 2016, PLoS pathogens.

[15]  Elizabeth P. Murchison,et al.  Rapid evolutionary response to a transmissible cancer in Tasmanian devils , 2016, Nature Communications.

[16]  A. B. Lyons,et al.  Mitogen‐activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells , 2016, Immunology and cell biology.

[17]  P. Ambros,et al.  Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human Schwann cell repair phenotype , 2016, Glia.

[18]  Andrew D. Rouillard,et al.  The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins , 2016, Database J. Biol. Databases Curation.

[19]  Christoph Bock,et al.  Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk. , 2016, Nature chemical biology.

[20]  S. Baldwin,et al.  Widespread transmission of independent cancer lineages within multiple bivalve species , 2016, Nature.

[21]  S. Rose-John,et al.  The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth , 2016, Oncotarget.

[22]  P. Lai,et al.  Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)‐Resistant CML Lines While Circumventing Pharmacokinetic Liabilities , 2016, ChemMedChem.

[23]  F. Garrido,et al.  The urgent need to recover MHC class I in cancers for effective immunotherapy , 2016, Current opinion in immunology.

[24]  M. Wellenreuther,et al.  Detecting Polygenic Evolution: Problems, Pitfalls, and Promises. , 2016, Trends in genetics : TIG.

[25]  A. B. Lyons,et al.  A second transmissible cancer in Tasmanian devils , 2015, Proceedings of the National Academy of Sciences.

[26]  Nathan C. Sheffield,et al.  Differential DNA Methylation Analysis without a Reference Genome , 2015, Cell reports.

[27]  A. Appert-Collin,et al.  Role of ErbB Receptors in Cancer Cell Migration and Invasion , 2015, Front. Pharmacol..

[28]  J. Deakin,et al.  Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes , 2015, Molecular Cytogenetics.

[29]  Y. Yarden,et al.  The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors , 2015, Oncogene.

[30]  A. B. Lyons,et al.  Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. , 2015, Vaccine.

[31]  S. Goff,et al.  Horizontal Transmission of Clonal Cancer Cells Causes Leukemia in Soft-Shell Clams , 2015, Cell.

[32]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[33]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[34]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[35]  Thomas Lengauer,et al.  Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.

[36]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[37]  J. Schlessinger,et al.  The EGFR family: not so prototypical receptor tyrosine kinases. , 2014, Cold Spring Harbor perspectives in biology.

[38]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[39]  A. Papenfuss,et al.  Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors , 2014, Anatomical record.

[40]  Peter J. Campbell,et al.  Transmissible Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage , 2014, Science.

[41]  David J. Arenillas,et al.  JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles , 2013, Nucleic Acids Res..

[42]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[43]  D. Parkinson,et al.  Plastic Fantastic: Schwann Cells and Repair of the Peripheral Nervous System , 2013, Stem cells translational medicine.

[44]  H. Siddle,et al.  How the devil facial tumor disease escapes host immune responses , 2013, Oncoimmunology.

[45]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[46]  Menna E. Jones,et al.  Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer , 2013, Proceedings of the National Academy of Sciences.

[47]  K. Nave,et al.  A role for Schwann cell–derived neuregulin-1 in remyelination , 2012, Nature Neuroscience.

[48]  Gur Pines,et al.  The ERBB network: at last, cancer therapy meets systems biology , 2012, Nature Reviews Cancer.

[49]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[50]  Carolyn Tregidgo,et al.  Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer , 2012, Cell.

[51]  C. Amemiya,et al.  Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour , 2012, PLoS genetics.

[52]  D. Radisky,et al.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. , 2012, Cold Spring Harbor perspectives in biology.

[53]  K. Ozato,et al.  Tripartite Motif-Containing Protein 28 Is a Small Ubiquitin-Related Modifier E3 Ligase and Negative Regulator of IFN Regulatory Factor 7 , 2011, The Journal of Immunology.

[54]  A. B. Lyons,et al.  Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil , 2011, PloS one.

[55]  A. Papenfuss,et al.  Tumor-Specific Diagnostic Marker for Transmissible Facial Tumors of Tasmanian Devils , 2011, Veterinary pathology.

[56]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[57]  Zlatko Trajanoski,et al.  Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ®-labelled specimens. , 2011, Journal of proteomics.

[58]  K. Belov.  The role of the Major Histocompatibility Complex in the spread of contagious cancers , 2011, Mammalian Genome.

[59]  C. Birchmeier,et al.  Nrg1/ErbB signaling networks in Schwann cell development and myelination. , 2010, Seminars in cell & developmental biology.

[60]  Joseph Schlessinger,et al.  Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases , 2010, Molecules and cells.

[61]  Timothy L. Bailey,et al.  Motif Enrichment Analysis: a unified framework and an evaluation on ChIP data , 2010, BMC Bioinformatics.

[62]  A. Fassati,et al.  Testing the theory of immune selection in cancers that break the rules of transplantation , 2009, Cancer Immunology, Immunotherapy.

[63]  Manolis Kellis,et al.  The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer , 2009, Science.

[64]  M. Greaves,et al.  Immunologically silent cancer clone transmission from mother to offspring , 2009, Proceedings of the National Academy of Sciences.

[65]  D. Levy,et al.  Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation , 2009, Science.

[66]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[67]  P. Fawcett,et al.  Function of Mitochondrial Stat3 in Cellular Respiration , 2009, Science.

[68]  William Stafford Noble,et al.  qvality: non-parametric estimation of q-values and posterior error probabilities , 2009, Bioinform..

[69]  Y. Sekine,et al.  Physical and functional interactions between STAT3 and KAP1 , 2008, Oncogene.

[70]  William Stafford Noble,et al.  Semi-supervised learning for peptide identification from shotgun proteomics datasets , 2007, Nature Methods.

[71]  Katherine Belov,et al.  Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial , 2007, Proceedings of the National Academy of Sciences.

[72]  A. O'hara,et al.  The Immunohistochemical Characterization of Devil Facial Tumor Disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii) , 2006, Veterinary pathology.

[73]  R. Sharpe,et al.  The Pathology of Devil Facial Tumor Disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii) , 2006, Veterinary pathology.

[74]  Robin A. Weiss,et al.  Clonal Origin and Evolution of a Transmissible Cancer , 2006, Cell.

[75]  A. Pearse,et al.  Allograft theory: Transmission of devil facial-tumour disease , 2006, Nature.

[76]  M. Mann,et al.  Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S , 2005, Molecular & Cellular Proteomics.

[77]  Hua Yu,et al.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity , 2005, Nature Medicine.

[78]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[79]  H. Lane,et al.  ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors , 2005, Nature Reviews Cancer.

[80]  H. Lane,et al.  ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.

[81]  H. Tettelin,et al.  Genome Sequencing and Analysis , 2005 .

[82]  Elior Peles,et al.  Mechanisms and Roles of Axon-Schwann Cell Interactions , 2004, The Journal of Neuroscience.

[83]  F. Ali-Osman,et al.  Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis , 2004, Oncogene.

[84]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[85]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[86]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[87]  Rolf Apweiler,et al.  VARSPLIC: alternatively-spliced protein sequences derived from SWISS-PROT and TrEMBL , 2000, Bioinform..

[88]  T. Ferguson,et al.  MMP-2 and MMP-9 Increase the Neurite-Promoting Potential of Schwann Cell Basal Laminae and Are Upregulated in Degenerated Nerve , 2000, Molecular and Cellular Neuroscience.

[89]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[90]  K. Shuai,et al.  The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities* , 1998, The Journal of Biological Chemistry.

[91]  J. Blenis,et al.  STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation , 1997, Molecular and cellular biology.

[92]  M. David,et al.  Preassociation of STAT1 with STAT2 and STAT3 in Separate Signalling Complexes Prior to Cytokine Stimulation (*) , 1996, The Journal of Biological Chemistry.

[93]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[94]  A. Shalev,et al.  Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells. , 1984, Journal of the National Cancer Institute.

[95]  E. Ostrander,et al.  Transmissible Tumors: Breaking the Cancer Paradigm. , 2016, Trends in genetics : TIG.

[96]  R. Roskoski.  The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.

[97]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[98]  S. Strickland,et al.  Peripheral regeneration. , 2007, Annual review of neuroscience.

[99]  Hua Yu,et al.  Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.